Aclaris Therapeutics, Inc. (ACRS)
NASDAQ: ACRS · Real-Time Price · USD
3.800
-0.520 (-12.04%)
At close: Nov 22, 2024, 4:00 PM
4.060
+0.260 (6.84%)
After-hours: Nov 22, 2024, 7:23 PM EST
Aclaris Therapeutics Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| TTM
| FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
| Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
| Net Income | -37 | -88.48 | -86.91 | -90.87 | -51.02 | -161.35 | |
| Depreciation & Amortization | 0.89 | 0.86 | 0.8 | 0.92 | 1.32 | 1.98 | |
| Asset Writedown & Restructuring Costs | 6.63 | 6.63 | - | - | - | 46.14 | |
| Stock-Based Compensation | 9.26 | 20.54 | 15.04 | 14.06 | 11.21 | 16.18 | |
| Other Operating Activities | -22.87 | -27.27 | 4.7 | 25.09 | 2.21 | 0.73 | |
| Change in Accounts Receivable | 0 | 0.19 | 0.14 | 0.15 | 4.9 | -0.81 | |
| Change in Accounts Payable | -1.61 | -1.47 | 0.37 | 3.66 | -5.22 | -3.16 | |
| Change in Other Net Operating Assets | 1.85 | 10.68 | -1.7 | -5.15 | -2.04 | 1.27 | |
| Operating Cash Flow | -17.9 | -78.33 | -67.57 | -52.13 | -38.63 | -96.45 | |
| Capital Expenditures | -0.56 | -1.31 | -0.61 | -0.31 | -0.45 | -1.61 | |
| Investment in Securities | 27.07 | 47.53 | 13.23 | -167.32 | 6.84 | 73.11 | |
| Other Investing Activities | - | - | - | - | - | 34.19 | |
| Investing Cash Flow | 26.5 | 46.22 | 12.63 | -167.63 | 6.39 | 105.68 | |
| Long-Term Debt Issued | - | - | - | - | 10.91 | - | |
| Long-Term Debt Repaid | - | - | - | -11.48 | -0.14 | -30.52 | |
| Net Debt Issued (Repaid) | - | - | - | -11.48 | 10.78 | -30.52 | |
| Issuance of Common Stock | 0.08 | 26.81 | 72.9 | 239.66 | 7.81 | 0.21 | |
| Repurchase of Common Stock | -0.08 | -0.1 | -0.03 | -3.12 | - | - | |
| Other Financing Activities | - | - | - | - | -0.21 | - | |
| Financing Cash Flow | 0.01 | 26.71 | 72.87 | 225.05 | 18.37 | -30.32 | |
| Net Cash Flow | 8.61 | -5.4 | 17.93 | 5.29 | -13.87 | -21.08 | |
| Free Cash Flow | -18.46 | -79.63 | -68.17 | -52.44 | -39.09 | -98.06 | |
| Free Cash Flow Margin | -68.17% | -254.84% | -229.13% | -775.65% | -602.99% | -2319.80% | |
| Free Cash Flow Per Share | -0.26 | -1.14 | -1.05 | -0.92 | -0.92 | -2.37 | |
| Levered Free Cash Flow | -22.05 | -39.92 | -39.31 | -28.51 | -18.59 | -45.26 | |
| Unlevered Free Cash Flow | -22.05 | -39.92 | -39.31 | -28.51 | -18.59 | -45.26 | |
| Change in Net Working Capital | -7.21 | -13.5 | 1.32 | 2.32 | 0.35 | 4.42 | |
Source: S&P Capital IQ. Standard template.
Financial Sources.